Skip to main content
logo
2seventy bio, Inc. (TSVT)
May 13, 2025 - TSVT was delisted (reason: acquired by BMY)
5.00
0.00 (0.00%)
Inactive · Last trade price on May 12, 2025

2seventy bio Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingMar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
48.3737.86100.3991.554.52248.12
Revenue Growth
-32.07%-62.28%9.72%67.81%-78.03%460.14%
Gross Profit
-13.24-61.62-147.29-183.46-220-53.74
Operating Income
-59.35-105.54-216.7-262.91-313.51-144.64
Net Income
-4.09-57.25-217.57-254.15-292.21-120.11
Earnings Per Share
-0.08-1.10-4.42-7.13-12.44-5.14
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingMar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Investments
173.36183.62221.81267.68362.180
Total Debt
239.76243.72256.67270.17282.22127.6
Net Cash (Debt)
-66.4-60.1-34.87-2.4979.97-127.6
Net Cash Growth
------
Net Cash Per Share
-1.27-1.15-0.71-0.073.40-5.46

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingMar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Cash Flow
-54.09-85-166.86-228.14-206.86-67.79
Capital Expenditures
-0.1-0.71-13.87-30.81-11.58-22.26
Free Cash Flow
-54.19-85.71-180.72-258.95-218.43-90.05
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingMar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Gross Margin
-27.37%-162.74%-146.72%-200.51%--21.66%
Operating Margin
-122.72%-278.75%-215.87%-287.34%-575.01%-58.29%
Pretax Margin
-8.46%-151.20%-216.73%-277.77%-535.95%-48.41%
Profit Margin
-8.46%-151.20%-216.73%-277.78%-535.95%-48.41%
FCF Margin
-112.04%-226.36%-180.03%-283.02%-400.63%-36.29%

Valuation
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJul '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
5.424.012.153.8810.99-